Bionano Genomics (BNGO) Free Cash Flow (2017 - 2025)
Historic Free Cash Flow for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$5.9 million.
- Bionano Genomics' Free Cash Flow rose 5566.91% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.7 million, marking a year-over-year increase of 7989.79%. This contributed to the annual value of -$69.0 million for FY2024, which is 4559.48% up from last year.
- Latest data reveals that Bionano Genomics reported Free Cash Flow of -$5.9 million as of Q3 2025, which was up 5566.91% from -$3.5 million recorded in Q2 2025.
- Bionano Genomics' 5-year Free Cash Flow high stood at -$2.8 million for Q1 2025, and its period low was -$37.2 million during Q2 2023.
- For the 5-year period, Bionano Genomics' Free Cash Flow averaged around -$21.5 million, with its median value being -$26.3 million (2021).
- Per our database at Business Quant, Bionano Genomics' Free Cash Flow tumbled by 13968.64% in 2022 and then surged by 9005.58% in 2025.
- Over the past 5 years, Bionano Genomics' Free Cash Flow (Quarter) stood at -$26.3 million in 2021, then tumbled by 37.35% to -$36.1 million in 2022, then grew by 15.37% to -$30.5 million in 2023, then surged by 78.69% to -$6.5 million in 2024, then grew by 9.29% to -$5.9 million in 2025.
- Its Free Cash Flow stands at -$5.9 million for Q3 2025, versus -$3.5 million for Q2 2025 and -$2.8 million for Q1 2025.